Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$489.07 USD
+2.87 (0.59%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $488.87 -0.20 (-0.04%) 6:50 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for Intuitive Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,124 | 6,222 | 5,710 | 4,358 | 4,479 |
Cost Of Goods | 2,395 | 2,026 | 1,752 | 1,497 | 1,368 |
Gross Profit | 4,730 | 4,196 | 3,959 | 2,861 | 3,110 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,963 | 2,619 | 2,138 | 1,811 | 1,736 |
Income After Depreciation & Amortization | 1,767 | 1,577 | 1,821 | 1,050 | 1,375 |
Non-Operating Income | 192 | 30 | 69 | 157 | 128 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 1,959 | 1,607 | 1,890 | 1,207 | 1,502 |
Income Taxes | 142 | 262 | 162 | 140 | 120 |
Minority Interest | 19 | 22 | 24 | 6 | 3 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,817 | 1,344 | 1,728 | 1,067 | 1,382 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,798 | 1,322 | 1,705 | 1,061 | 1,379 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,229 | 1,970 | 2,153 | 1,343 | 1,591 |
Depreciation & Amortization (Cash Flow) | 462 | 392 | 332 | 293 | 216 |
Income After Depreciation & Amortization | 1,767 | 1,577 | 1,821 | 1,050 | 1,375 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 357.40 | 362.00 | 365.80 | 360.90 | 358.50 |
Diluted EPS Before Non-Recurring Items | 4.05 | 3.65 | 4.66 | 2.94 | 3.32 |
Diluted Net EPS (GAAP) | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 |
Fiscal Year end for Intuitive Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,009.90 | 1,890.60 | 1,928.30 | 1,743.70 | 1,755.90 |
Cost Of Goods | 637.20 | 645.20 | 650.90 | 576.50 | 584.00 |
Gross Profit | 1,372.70 | 1,245.40 | 1,277.40 | 1,167.20 | 1,171.90 |
SG&A, R&D, and Dept/Amort Expenses | 805.40 | 776.00 | 827.20 | 701.40 | 708.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 567.30 | 469.40 | 450.20 | 465.80 | 463.20 |
Non-Operating Income | 87.20 | 69.10 | 65.70 | 56.20 | 36.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 654.50 | 538.50 | 515.90 | 522.00 | 499.20 |
Income Taxes | 123.00 | -8.90 | -94.80 | 102.20 | 73.20 |
Minority Interest | 4.60 | 2.50 | 4.50 | 4.10 | 5.20 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 531.50 | 547.40 | 610.70 | 419.80 | 426.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 526.90 | 544.90 | 606.20 | 415.70 | 420.80 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 361.00 | 360.50 | 358.20 | 358.20 | 357.30 |
Diluted EPS Before Non-Recurring Items | 1.47 | 1.16 | 1.18 | 1.16 | 1.18 |
Diluted Net EPS (GAAP) | 1.46 | 1.51 | 1.69 | 1.16 | 1.18 |